SLATE-001

N/A

Report date: 2026/05/12 09:09:29

Base Information

Drug NameSLATE-001
Drug Alias NameSLATE-KRASSLATE Version (v)1SLATEGRT-C903SLATE-001 +[7] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccine > Viral vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursUrogenital NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGritstone Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteGritstone Bio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrogenital NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A